RKDA underwent a major business transformation, divesting substantially all operating assets and completing a reverse merger with Roosevelt partnership, resulting in dramatic shrinkage across all financial metrics.
The company has fundamentally changed from an active producer of plant-based products, wheat innovations, coconut water, and CBD body care brands to what appears to be a shell entity post-divestiture. The 50% increase in outstanding shares combined with massive asset reduction suggests existing shareholders experienced severe dilution through the Roosevelt partnership exchange, where Limited Partners received 90% ownership.
The financial statements reflect a company in dramatic contraction, with cash plummeting 94% to just $259K, total assets halving to $6.5M, and stockholders' equity declining 52% to $6.2M. While net losses improved from -$7.0M to -$2.3M and operating cash flow losses narrowed from -$9.6M to -$4.7M, this appears driven by asset sales rather than operational improvements. The 34% inventory increase is puzzling given the apparent divestiture of operating businesses, suggesting either remaining inventory from divested operations or new business activities not clearly described in the filing.
Cash declined 93.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
R&D spending cut 83% — could signal cost discipline or concerning reduction in innovation investment.
Liabilities reduced 67% — deleveraging improves balance sheet strength and financial flexibility.
Net income grew 66.8% — bottom-line growth signals improving overall business health.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Total assets contracted 51.6% — asset sales, write-downs, or balance sheet optimization underway.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Operating cash flow surged 50.8% — exceptional cash generation, highest quality earnings signal.
Inventory surged 34.1% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →